These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 29570262)

  • 1. Polygamy, sexual behavior in a population under risk for prostate cancer diagnostic: an observational study from the Black Sea Region in Turkey.
    Cirakoglu A; Benli E; Yuce A
    Int Braz J Urol; 2018; 44(4):704-708. PubMed ID: 29570262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comment on 'polygamy, sexual behavior in a population under risk for prostate cancer diagnostic: an observational study from the black sea region in Turkey'.
    Özkidik M; İbrahimov A
    Int Braz J Urol; 2018; 44(6):1275-1276. PubMed ID: 30325615
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prognostic significance of prostate-specific antigen in defining indications for initial prostate biopsy].
    Popov SV; Guseinov RG; Skryabin ON; Orlov IN; Martov AG
    Urologiia; 2018 Jul; (3):92-97. PubMed ID: 30035426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. REPLY BY THE AUTHORS: Comment on Polygamy, Sexual Behavior in a Population Under Risk for Prostate Cancer Diagnostic: An Observational Study From the Black Sea Region in Turkey.
    Cirakoglu A; Benli E; Yuce A
    Int Braz J Urol; 2020; 46(5):877-878. PubMed ID: 32539250
    [No Abstract]   [Full Text] [Related]  

  • 5. Histological inflammation and risk of subsequent prostate cancer among men with initially elevated serum prostate-specific antigen (PSA) concentration in the Finnish prostate cancer screening trial.
    Yli-Hemminki TH; Laurila M; Auvinen A; Määttänen L; Huhtala H; Tammela TL; Kujala PM
    BJU Int; 2013 Oct; 112(6):735-41. PubMed ID: 23746332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sexual Activity and Risk of Prostate Cancer: A Dose-Response Meta-Analysis.
    Jian Z; Ye D; Chen Y; Li H; Wang K
    J Sex Med; 2018 Sep; 15(9):1300-1309. PubMed ID: 30122473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of serum prostate-specific antigen levels with the results of the prostate needle biopsy.
    Janbaziroudsari H; Mirzaei A; Maleki N
    Bull Cancer; 2016 Sep; 103(9):730-4. PubMed ID: 27345449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination.
    Uzzo RG; Pinover WH; Horwitz EM; Parlanti A; Mazzoni S; Raysor S; Mirchandani I; Greenberg RE; Pollack A; Hanks GE; Watkins-Bruner D
    Urology; 2003 Apr; 61(4):754-9. PubMed ID: 12670560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there any association between prostate-specific antigen screening frequency and uptake of active surveillance in men with low or very low risk prostate cancer?
    Beckmann K; Kinsella N; Olsson H; Wallerstedt Lantz A; Nordstrom T; Aly M; Adolfsson J; Eklund M; Van Hemelrijck M
    BMC Urol; 2019 Aug; 19(1):73. PubMed ID: 31383015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of prostate-specific antigen on a baseline prostate cancer risk assessment including genetic risk.
    Kader AK; Liss MA; Trottier G; Kim ST; Sun J; Zheng SL; Chadwick K; Lockwood G; Xu J; Fleshner NE
    Urology; 2015 Jan; 85(1):165-70. PubMed ID: 25530379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary prostate cancer prevalence among T1c biopsy-referred men with a prostate-specific antigen level < or = 4.0 ng per milliliter.
    Ahyai SA; Graefen M; Steuber T; Haese A; Schlomm T; Walz J; Köllermann J; Briganti A; Zacharias M; Friedrich MG; Karakiewicz PI; Montorsi F; Huland H; Chun FK
    Eur Urol; 2008 Apr; 53(4):750-7. PubMed ID: 17964070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended use of P504S positive primary circulating prostate cell detection to determine the need for initial prostate biopsy in a prostate cancer screening program in Chile.
    Murray NP; Reyes E; Fuentealba C; Jacob O; Orellana N
    Asian Pac J Cancer Prev; 2014; 15(21):9335-9. PubMed ID: 25422221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel algorithm for the prediction of prostate cancer in clinically suspected patients.
    Gallotta A; Ziglioli F; Ferretti S; Maestroni U; Moretti M; Aloe R; Gnocchi C; Di Palo M; Fassina G
    Cancer Biomark; 2013; 13(4):227-34. PubMed ID: 24240583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [PSA testing, biopsy and cancer and benign prostate hyperplasia in France].
    Tuppin P; Samson S; Fagot-Campagna A; Lukacs B; Alla F; Allemand H; Paccaud F; Thalabard JC; Vicaut E; Vidaud M; Millat B
    Prog Urol; 2014 Jul; 24(9):572-80. PubMed ID: 24975792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there any association between National Institute of Health category IV prostatitis and prostate-specific antigen levels in patients with low-risk localized prostate cancer?
    Doluoglu OG; Ceylan C; Kilinc F; Gazel E; Resorlu B; Odabas O
    Int Braz J Urol; 2016; 42(2):346-50. PubMed ID: 27256190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostatic cancer, coital rates, vasectomy and testosterone.
    James WH
    J Biosoc Sci; 1994 Apr; 26(2):269-72. PubMed ID: 8014182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of PSA and DRE on histologic findings at prostate biopsy in Turkish men over 75 years of age.
    Verim L; Yildirim A; Basok EK; Peltekoglu E; Pelit ES; Zemheri E; Tokuc R
    Asian Pac J Cancer Prev; 2013; 14(10):6085-8. PubMed ID: 24289630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the digital rectal examination as diagnostic test for prostate cancer detection in obese patients.
    Dell'Atti L
    J BUON; 2015; 20(6):1601-5. PubMed ID: 26854458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy.
    Auprich M; Augustin H; Budäus L; Kluth L; Mannweiler S; Shariat SF; Fisch M; Graefen M; Pummer K; Chun FK
    BJU Int; 2012 Jun; 109(11):1627-35. PubMed ID: 21939492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.